Babu Yarlagadda S
Insider CIK 1452635 · BCRX VP Drug Discovery
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2022-11-14 | 2022-11-16 | 50,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2022-11-14 | 2022-11-16 | 50,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2022-11-14 | 2022-11-16 | 50,000 | $1.42 | $71.0K | 330,056 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-11-14 | 2022-11-16 | 31,515 | $13.88 | $437.4K | 298,541 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2022-11-14 | 2022-11-16 | 50,000 | $1.42 | $71.0K | 280,056 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-03-07 | 2022-03-09 | 20,000 | $17.16 | $343.2K | 230,056 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-12-14 | 2021-12-16 | 164,000 | — | $0 | 164,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2021-12-16 | 35,000 | — | $0 | 250,056 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-12-07 | 2021-12-09 | 62,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-12-07 | 2021-12-09 | 62,000 | $4.73 | $293.3K | 245,156 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-12-07 | 2021-12-09 | 30,100 | $12.20 | $367.2K | 215,056 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-02-19 | 2021-02-23 | 50,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-02-19 | 2021-02-23 | 50,000 | $4.15 | $207.5K | 205,587 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2021-02-19 | 2021-02-23 | 22,431 | $11.53 | $258.6K | 183,156 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-15 | 2020-12-17 | 280,000 | — | $0 | 280,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-03 | 2020-12-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-21 | 2020-02-25 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-14 | 2020-02-19 | 31,500 | — | $0 | 31,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-12-17 | 2019-12-19 | 225,000 | — | $0 | 225,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2019-11-18 | 2019-11-18 | 25,000 | $1.45 | $36.3K | 155,587 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-01-31 | 2019-02-04 | 19,686 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-01-31 | 2019-02-04 | 12,188 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-01-31 | 2019-02-04 | 19,686 | $1.20 | $23.6K | 127,786 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2019-01-31 | 2019-02-04 | 7,702 | $8.68 | $66.9K | 120,084 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-01-31 | 2019-02-04 | 12,188 | $1.20 | $14.6K | 132,272 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2019-01-31 | 2019-02-04 | 1,685 | $8.68 | $14.6K | 130,587 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2019-01-01 | 2019-01-03 | 771 | $8.07 | $6.2K | 108,100 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-12-20 | 2018-12-21 | 235,000 | — | $0 | 235,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-03-06 | 2018-03-08 | 20,622 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-03-06 | 2018-03-08 | 9,378 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-03-06 | 2018-03-08 | 15,223 | $5.18 | $78.9K | 105,395 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-03-06 | 2018-03-08 | 9,378 | $3.26 | $30.6K | 114,773 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-03-06 | 2018-03-08 | 5,902 | $5.18 | $30.6K | 108,871 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-03-06 | 2018-03-08 | 20,622 | $3.26 | $67.2K | 120,618 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-20 | 2018-01-23 | 3,872 | $5.59 | $21.6K | 99,996 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-01 | 2018-01-03 | 838 | $4.91 | $4.1K | 103,868 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-12-20 | 2017-12-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-08-31 | 2017-09-05 | 27,000 | — | $0 | 27,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-02-27 | 2017-03-01 | 175,000 | — | $0 | 175,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-20 | 2017-01-24 | 5,083 | $5.95 | $30.2K | 104,706 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-01 | 2017-01-03 | 1,639 | $6.33 | $10.4K | 109,789 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2016-08-25 | 2016-08-29 | 30,000 | $4.06 | $121.8K | 111,428 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 129,427 | — | $0 | 129,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-03-01 | 2016-03-03 | 906 | $2.13 | $1.9K | 141,428 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-20 | 2016-01-22 | 4,724 | $7.55 | $35.7K | 142,334 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-01 | 2016-01-05 | 1,639 | $10.32 | $16.9K | 147,058 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-12-29 | 2015-12-31 | 62,573 | — | $0 | 62,573 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-05-13 | 2015-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-03-19 | 2015-03-20 | 12,105 | $10.16 | $123.0K | 148,697 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-03-05 | 2015-03-06 | 37,400 | $10.59 | $396.1K | 160,802 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-03-04 | 2015-03-05 | 10,495 | $10.50 | $110.2K | 198,202 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-03-01 | 2015-03-03 | 1,634 | $10.20 | $16.7K | 208,697 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-20 | 2015-01-22 | 4,362 | $11.17 | $48.7K | 210,331 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-01-01 | 2015-01-05 | 42,400 | — | $0 | 42,400 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-01 | 2015-01-05 | 2,402 | $12.16 | $29.2K | 214,693 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-01-01 | 2015-01-05 | 8,900 | — | $0 | 217,095 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-12-19 | 2014-12-23 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-05-26 | 2014-05-28 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-04 | 2014-03-07 | 2,929 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-04 | 2014-03-07 | 2,208 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-04 | 2014-03-07 | 23,679 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-04 | 2014-03-07 | 23,679 | $8.83 | $209.1K | 248,837 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-04 | 2014-03-07 | 2,208 | $8.83 | $19.5K | 222,229 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-03-04 | 2014-03-07 | 40,642 | $12.57 | $510.9K | 208,195 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-04 | 2014-03-07 | 2,929 | $4.30 | $12.6K | 225,158 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-03-01 | 2014-03-07 | 1,618 | $11.69 | $18.9K | 220,021 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-02-24 | 2014-02-25 | 23,179 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-02-24 | 2014-02-25 | 23,179 | $4.30 | $99.7K | 229,809 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-02-24 | 2014-02-25 | 8,170 | $12.20 | $99.7K | 221,639 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-01-20 | 2014-02-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2014-01-20 | 2014-02-04 | 54,000 | — | $0 | 206,630 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-01-01 | 2014-01-03 | 2,402 | $7.60 | $18.3K | 152,630 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2013-03-01 | 2013-03-06 | 1,903 | $1.19 | $2.3K | 155,032 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-01-01 | 2013-01-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-01-01 | 2013-01-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-01-07 | 8,500 | — | $0 | 156,935 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-01-07 | 8,500 | — | $0 | 148,435 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2012-03-15 | 2012-03-19 | 21,038 | — | $0 | 146,807 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2012-03-15 | 2012-03-19 | 6,872 | $5.23 | $35.9K | 139,935 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2012-03-02 | 2012-03-05 | 837 | $4.78 | $4.0K | 125,769 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2012-03-01 | 2012-03-05 | 62,000 | $4.73 | $293.3K | 62,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2012-03-01 | 2012-03-05 | 11,200 | — | $0 | 126,606 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2012-02-29 | 2012-03-01 | 6,608 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2012-02-29 | 2012-03-01 | 13,126 | — | $0 | 31,874 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2012-02-29 | 2012-03-01 | 1,834 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2012-02-29 | 2012-03-01 | 921 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2012-02-29 | 2012-03-01 | 31,179 | — | $0 | 45,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2012-02-29 | 2012-03-01 | 921 | — | $0 | 55,493 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2012-02-29 | 2012-03-01 | 1,834 | — | $0 | 54,572 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2012-02-29 | 2012-03-01 | 13,126 | — | $0 | 106,406 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2012-02-29 | 2012-03-01 | 31,179 | — | $0 | 93,280 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2012-02-29 | 2012-03-01 | 6,608 | — | $0 | 62,101 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2012-02-22 | 2012-02-23 | 1,226 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2012-02-22 | 2012-02-23 | 23,821 | — | $0 | 76,179 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2012-02-22 | 2012-02-23 | 5,865 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2012-02-22 | 2012-02-23 | 1,226 | $1.04 | $1.3K | 59,829 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2012-02-22 | 2012-02-23 | 5,865 | $1.18 | $6.9K | 58,603 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2012-02-22 | 2012-02-23 | 23,821 | $1.20 | $28.6K | 83,650 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2012-02-22 | 2012-02-23 | 30,912 | $4.22 | $130.4K | 52,738 | SEC↗ |